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INTRODUCTION
Untreated severe combined immune deficiency is a fatal disorder characterized by deficient B and T cell function and marked susceptibility to infection. Although severe combined immunodeficiency can result from a number of pathogenetic mechanisms (1) (2) (3) (4) , the treatment of choice is transplantation of normal lymphoid precursor cells to establish a new clone of self-replicating cells that differentiate into functional lymphocytes. The two tissues that have been used as a source of lymphoid precursor cells are bone marrow and fetal liver. Transplantation of bone marrow from histocompatible donors results in engraftment in a majority of cases (5) . Transplantation of fetal liver has been successful on a few occasions (6) .
Another source of lymphoid precursor cells may be peripheral blood. Cryopreserved autologous or histocompatible allogeneic peripheral blood leukocytes are capable of reconstituting lethally irradiated dogs with lymphoid cells as well as hematopoietic cells (7) (8) (9) .
Although granulocytic and erythroid precursor cells are present in human peripheral blood (10) (11) (12) (13) , there is no direct evidence that lymphoid progenitors circulate in humans. We recently had the opportunity to test the hypothesis that lymphoid precursor cells were present in human peripheral blood. The patient was adenosine deaminase (ADA)' deficient with combined immune deficiency. His father was histocompatible and therefore a potential donor for bone marrow. However, for personal reasons he refused to donate bone marrow, although he did consent to leukopheresis. A successful transplant was performed using peripheral blood leukocytes that resulted in engraftment and establishment of normal in vivo and in vitro immune function.
METHODS
Donor mononuclear leukocytes were obtained by leukopheresis using the Haemonetics model 30 semicontinuous flow cell separator (Haemonetics Corp., Natick, Mass.) as previously described (14) . Because the recipient was type A Rh positive and the donor type 0 Rh positive, the donor cells were gently centrifuged and resuspended in type A freshly frozen irradiated plasma. 5 x 107 mononuclear cells/ kg were infused intravenously into the recipient.
Quantitative immunoglobulins were determined by radial immunodiffusion, (Meloy Laboratories, Inc., Springfield, Va.). Phytohemagglutinin (PHA)-stimulated blastogenesis was assayed by tritiated thymidine incorporation using multiple doses of PHA-P (Burroughs Welcome Co., Research Triangle Park, N. C. sample was lysed by freezing and thawing (three times), dialyzed against Tris-saline buffer pH 7.4, and assayed for ADA activity by a previously described radiochemical method (17) . For the determination of dATP the method of Solter and Handschumacher was used (18) . dATP was extracted from a known number of mononuclear cells by overnight incubation with 1 ml of cold 60% aqueous methaniol. The methanol was evaporated and the residual dissolved in 50-100 ,l of distilled water for assay. dATP was extracted from erythrocytes with cold 2 M perchloric acid and neutralized with KOH. The extract was lyophilizecl and the residue dissolved in 200 ,ul of distilled water for assay. A stanidard curve for each assay was linear from 2 to 20 pM of dATP and the samples were diluted to fall within this range.
Case history
The patient presented at 16 (Table I) .
At 10 mo of age, a transplant of peripheral blood leukocytes from the patient's father was performed. On the day after the transplant, the patient was started on a course of intravenous methotrexate using the protocol established by Thomas et al. (21) to modify graft vs. host disease. The methotrexate was used because a large number of mature lymphocytes were to be given and the severity of graft vs. host disease could not be predicted with certainty from the mo of age and has continued to grow well. He has had episodes of pneumococcal and Haemophilus influenze ba,cteremia without localizing source and an episode of herpetic stomatitis. However, during the last 5 mo of the 12-mo posttransplant observation period, he did not have significant illness and did not require hospitalization.
RESULTS
Before transplant, the absolute lymphocyte count was generally depressed although increased counts were noted coincident with severe illness. During the 5 mo immediately preceding the transplant, the absolute count of lymphocytes was persistently depressed. The count remained depressed after the transplant until day 21 when it increased to 3,750/mm3 (Fig. 1A) (Fig. 2B) . The level of ADA activity subsequently plateaued at -25% of normal and is similar in value to the father's mononuclear leukocyte ADA activity. The reason for the increase in specific activity of the ADA above the normal activity of the donor cells is unclear but the persistence of ADA containing mononuclear leukocytes is evidence for engraftment of a clone of donor cells.
Erythrocyte transfusions were associated with a decrease in erythrocyte dATP. After the transplant, the concentration continued to decrease and by day 136 was normal (Fig. 3A) . It increased dramatically to twice the pretransfusion values by day 270. Mononuclear leukocyte dATP was not measured before the transplant but afterwards the concentration varied from lower than normal to elevated. By day 136 mononuclear leukocyte dATP was normal and remained normal through day 329 (Fig. 3B) .
DISCUS SION
The mechanism by which the deficiency of ADA results in immune abnormalities is controversial. The excess deoxyadenosine that accumulates in ADAdeficient lymphocytes is directly toxic to cells in vitro (24) . dATP also accumulates and may inhibit ribonucleotide reductase activity resulting in decreased DNA synthesis (25) . We attempted to treat the biochemical defect in our patient initially with transfusions of ADA containing frozen irradiated erythrocytes. We observed increased serum immunoglobulin levels coincident with the transfusions, but no change in T cell function. We also found, as did Donofrio et al. (26) , that erythrocyte dATP levels fell during transfusions. This suggests improved purine catabolism. The improvement in the B-lymphocyte function but not in T cell function is consistent with the observation that B lymphoblasts are more resistent to the toxic effects of adenosine and deoxyadenosine in the presence of an inhibitor of ADA than T lymphoblasts (24) . Others found transfusions to be useful in some patients but not in all (26, 27) .
The inability to completely correct the immune function suggested the possibility that the metabolic abnormality had resulted in the loss of a population of lymphoid precursors capable of being rescued by the erythrocyte transfusions. Therefore, replacement of stem cells as well as improved adenosine and deoxyadenosine metabolism might be necessary for the development of normal immune function. Bone mar- in the ability to respond to a diverse spectrum of antigens. Whether this is a quantitative abnormality that will improve with time or a qualitative defect, as might result from a lack of uncommitted progenitor cells in the donor circulation, is unclear. In addition, there is no evidence of red cell engraftment. This is in accordance with a previous report of bone marrow transplants in ADA-deficient patients that showed only mononuclear leukocyte engraftment in two of three patients (28) .
Reconstitution of immune-deficient patients with peripheral blood leukocytes may be an acceptable alternative to bone marrow transplantation in some patients. It is a simple procedure that carries little risk to the donor and requires no unusual equipment. However, long term follow-up in this and other patients treated in a similar manner is necessary to evaluate the persistence of the graft and to rule out unexpected adverse effects.
